Larvol Delta - Adiso-Therapeutics-Announces-Completion-of-First-Cohort-Enrollment-in-a-Phase-1b-Study-of-ADS051-for-the-Treatment-of-ModeratelytoSeverely-Active-Ulcerative-Colitis

ADS051 - Adiso Therap

https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-completion-of-first-cohort-enrollment-in-a-phase-1b-study-of-ads051-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis-301524293.html

Apr 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next